The Carlyle Group L.P. is a global alternative asset management firm. The Company advises an array of specialized investment funds and other investment vehicles that invest across a range of industries, geographies, asset classes and investment strategies. The Company conducts its operations through four segments: Corporate Private Equity, Real Assets, Global Market Strategies and Fund of Funds Solutions. Its Corporate Private Equity segment advises the Company�s buyout and growth capital funds. The Real Assets segment advises the Company�s United States and internationally-focused real estate and infrastructure funds, as well as its energy and renewable resources funds. Effective June 2, 2014, The Carlyle Group LP acquired an undisclosed majority interest in Talent Partners Inc. In July 2014, Johnson & Johnson completed the divestiture of Ortho-Clinical Diagnostics business to Carlyle Group. Effective August 07, 2014, the Carlyle Group LP acquired Sunsho Pharmaceutical Co Ltd.